                         SEQUENCE LISTING

<110>  St. Jude Children's Research Hospital
       McCullers, Jonathan A.
 
<120>  Method for Preventing or Treating a Bacterial Infection

<130>  SJ0062WO

<150>  US 61/526,784
<151>  2011-08-24

<160>  36    

<170>  PatentIn version 3.5

<210>  1
<211>  90
<212>  PRT
<213>  Influenza A virus

<400>  1

Met Glu Gln Glu Gln Asp Thr Pro Trp Thr Gln Ser Thr Glu His Ile 
1               5                   10                  15      


Asn Ile Gln Lys Lys Gly Ser Gly Gln Gln Thr Arg Lys Leu Glu Arg 
            20                  25                  30          


Pro Asn Leu Thr Gln Leu Met Asp His Tyr Leu Arg Ile Met Ser Gln 
        35                  40                  45              


Val Asp Met His Lys Gln Thr Val Ser Trp Lys Gln Trp Leu Ser Leu 
    50                  55                  60                  


Lys Asn Pro Thr Gln Gly Ser Leu Lys Thr Arg Val Leu Lys Arg Trp 
65                  70                  75                  80  


Lys Leu Phe Asn Lys Gln Gly Trp Thr Asp 
                85                  90  


<210>  2
<211>  90
<212>  PRT
<213>  Influenza A virus

<400>  2

Met Glu Gln Glu Gln Asp Thr Pro Trp Thr Gln Ser Thr Glu His Thr 
1               5                   10                  15      


Asn Ile Gln Lys Lys Gly Ser Gly Arg Gln Thr Gln Lys Leu Gly His 
            20                  25                  30          


Pro Asn Ser Thr Arg Leu Met Asp His Tyr Leu Arg Ile Met Ser Gln 
        35                  40                  45              


Val Asp Met His Lys Gln Thr Val Ser Trp Arg Pro Trp Pro Ser Leu 
    50                  55                  60                  


Lys Asn Pro Thr Gln Gly Ser Leu Arg Thr His Val Leu Lys Gln Trp 
65                  70                  75                  80  


Lys Ser Phe Asn Lys Gln Gly Trp Thr Asn 
                85                  90  


<210>  3
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa denotes between 1 and 61 consecutive amino acid residues of 
       the N-terminus of an influenza A virus PB1-F2 peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa denotes the amino acid residue at position 63 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa denotes the amino acid residue at position 64 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa denotes the amino acid residue at position 65 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa denotes the amino acid residue at position 66 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa denotes the amino acid residue at position 67 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa denotes the amino acid residue at position 68 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa denotes the amino acid residue at position 69 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa denotes the amino acid residue at position 70 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa denotes the amino acid residue at position 71 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa denotes the amino acid residue at position 72 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa denotes the amino acid residue at position 73 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa denotes the amino acid residue at position 74 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa denotes the amino acid residue at position 76 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa denotes the amino acid residue at position 77 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa denotes the amino acid residue at position 78 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa denotes the amino acid residue at position 80 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa denotes the amino acid residue at position 81 of a wild-type 
       PB1-F2

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa denotes between 1 and 8 consecutive amino acid residues of 
       the C-terminus of an influenza A virus PB1-F2 peptide

<400>  3

Xaa Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa His Xaa 
1               5                   10                  15      


Xaa Xaa Gln Xaa Xaa Ser Xaa 
            20              


<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Gly His Pro Asn Ser Thr Arg Leu Met Asp His Tyr Leu Arg Ile Met 
1               5                   10                  15      


Ser Gln Val Asp Met His Lys Gln Thr Val Ser Trp Arg Pro Trp 
            20                  25                  30      


<210>  5
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

His Tyr Leu Arg Ile Met Ser Gln Val Asp Met His Lys Gln Thr Val 
1               5                   10                  15      


Ser Trp Arg Pro Trp 
            20      


<210>  6
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Glu Arg Pro Asn Leu Thr Gln Leu Met Asp His Tyr Leu Arg Ile Met 
1               5                   10                  15      


Ser Gln Val Asp Met His Lys Gln Thr Val Ser Trp Lys Gln Trp 
            20                  25                  30      


<210>  7
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Gln Gln Thr Gln Lys Leu Gly Arg Pro Asn Leu Thr Gln Leu Met Asp 
1               5                   10                  15      


His Tyr Leu Arg Ile Met Ser Gln Val Asp Met His Lys Gln Thr Val 
            20                  25                  30          


Ser Trp Lys Gln Trp 
        35          


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Ile Met Ser Gln Met Asp Met His Lys Gln Thr Val Ser Trp Lys Gln 
1               5                   10                  15      


Trp 
    


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Met His Lys Gln Thr Val Ser Trp Lys Leu Trp 
1               5                   10      


<210>  10
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Asp His Tyr Leu Arg Ile Met Ser Gln Val Asp Met His Lys Gln Thr 
1               5                   10                  15      


Val Phe Trp Arg Pro Trp 
            20          


<210>  11
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Lys Arg Gly Ser Gly Arg Gln Ile Gln Lys Leu Gly His Pro Asn Ser 
1               5                   10                  15      


Thr Gln Leu Met Asp His Tyr Leu Arg Ile Met Ser Gln Val Asp Met 
            20                  25                  30          


His Lys Gln Thr Val Ser Trp Lys Leu Trp 
        35                  40          


<210>  12
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Asp His Tyr Leu Arg Ile Met Asn Gln Val Asp Met His Lys Gln Thr 
1               5                   10                  15      


Val Ser Trp Arg Leu Trp 
            20          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Val Met Pro Lys Gln Ile Val Tyr Trp Lys Gln Trp 
1               5                   10          


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Ile Val Tyr Trp Lys Gln Trp 
1               5           


<210>  15
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Asp His Cys Leu Arg Ile Met Ser Arg Val Gly Met His Lys Gln Ile 
1               5                   10                  15      


Val Tyr Trp Lys Gln Trp 
            20          


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa denotes Thr or Ile

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa denotes Ser, Phe or Tyr

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa denotes Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa denotes Pro, Leu or Gln

<400>  16

Xaa Val Xaa Trp Xaa Xaa Trp 
1               5           


<210>  17
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa denotes Asp, Val or Gly

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa denotes His or Pro

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa denotes Thr or Ile

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa denotes Ser, Phe or Tyr

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa denotes Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa denotes Pro, Leu or Gln

<400>  17

Xaa Met Xaa Lys Gln Xaa Val Xaa Trp Xaa Xaa Trp 
1               5                   10          


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Ser Leu Lys Asn Pro Thr Gln Gly Ser Leu Arg Thr 
1               5                   10          


<210>  19
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Ser Leu Lys Asn Pro Thr Gln Gly Ser Leu Lys Thr 
1               5                   10          


<210>  20
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Ser Leu Arg Asn Pro Thr Gln Gly Ser Leu Arg Thr 
1               5                   10          


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  21

Ser Ser Lys Asn Pro Thr Gln Val Ser Leu Arg Thr 
1               5                   10          


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Ser Leu Arg Asn Pro Ile Leu Val Phe Leu Lys Thr 
1               5                   10          


<210>  23
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  23

Ser Leu Arg Ser Pro Thr Pro Val Ser Leu Lys Thr 
1               5                   10          


<210>  24
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa denotes Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa denotes Asn or Ser

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa denotes Thr or Ile

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa denotes Gln, Leu or Pro

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa denotes Gly or Val

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa denotes Ser or Phe

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa denotes Arg or Lys

<400>  24

Ser Leu Xaa Xaa Pro Xaa Xaa Xaa Xaa Leu Xaa Thr 
1               5                   10          


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  25

Phe Asn Lys Gln Gly Trp Thr Asn 
1               5               


<210>  26
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  26

Phe Asn Lys Gln Gly Trp Thr Asp 
1               5               


<210>  27
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  27

Phe Asn Lys 
1           


<210>  28
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Phe Asn Lys Gln Gly 
1               5   


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  29

Phe Asn Lys Gln Gly Trp Thr 
1               5           


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  30

Phe Asn Lys Gln Gly Trp 
1               5       


<210>  31
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  31

Phe Asn Arg Gln Gly Trp Thr Asn 
1               5               


<210>  32
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  32

Phe Ser Lys His Glu 
1               5   


<210>  33
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  33

Phe Ser Lys His Glu Trp Thr Ser 
1               5               


<210>  34
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  34

Phe Ser Lys Gln Glu Trp Ile Asn 
1               5               


<210>  35
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  35

Trp Leu Ser Leu Lys Asn Pro Thr Gln Gly Ser Leu Lys Thr Arg Val 
1               5                   10                  15      


Leu Lys Arg Trp Lys Leu Phe Asn Lys Gln Gly 
            20                  25          


<210>  36
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  36

Trp Pro Ser Leu Lys Asn Pro Thr Gln Gly Ser Leu Arg Thr His Val 
1               5                   10                  15      


Leu Lys Gln Trp Lys Ser Phe Asn Lys Gln Gly 
            20                  25          


